Invacare SOLO2 Approved by FAA for Air Travel
Invacare Corp.'s SOLO2 Transportable Concentrator has been approved by the Federal Aviation Administration for use on board passenger aircrafts.
"Invacare's complete line of oxygen solutions encourages active lifestyles," said Joe Lewarski, vice president of
the Invacare respiratory division. "Following the success of the Invacare XPO2 Portable Concentrator for in-flight use, we are pleased to offer patients another option to meet their oxygen needs while traveling."
The SOLO2 Transportable Concentrator features continuous flow at 1-3 lpm and pulse dose at 1-5. It comes standard with a wheeled cart, Invacare Sensi-Pulse Technology, and battery, AC or DC operation for patient convenience, according to the Elyria, Ohio-based manufacturer.